Greenwich LifeSciences (GLSI) Stock Chart & Stock Price History $10.84 -0.38 (-3.39%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$10.82 -0.02 (-0.14%) As of 07/11/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Greenwich LifeSciences Stock Price Performance The Greenwich LifeSciences (GLSI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.65%, with a year-to-date return of -3.47%. In the past month, the stock has increased 17.83%, reflecting recent market activity. As of the latest close, Greenwich LifeSciences traded at $10.84 with a market cap of $144.93 million and volume of 60,219 shares. Receive GLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.75%1 Month Performance+17.83%3 Month Performance+16.81%Year-To-Date Performance-3.47%1 Year Performance-30.65% GLSI Stock Chart for Monday, July, 14, 2025 GLSI Chart by TradingView Greenwich LifeSciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$11.22$10.84-3.39%$11.52$10.7560,219 shs$144.93 million07/10/2025$10.55$11.22+6.35%$11.29$10.4572,635 shs$149.99 million07/09/2025$10.09$10.55+4.56%$10.58$10.0535,299 shs$141.05 million07/08/2025$10.07$10.09+0.20%$10.21$10.0433,144 shs$134.90 million07/07/2025$10.04$10.07+0.35%$10.32$9.9036,195 shs$134.64 million07/04/2025$10.04$10.04$10.23$9.8531,423 shs$134.17 million07/03/2025$9.88$10.04+1.57%$10.23$9.8531,423 shs$134.15 million07/02/2025$9.05$9.88+9.17%$9.89$9.0073,618 shs$132.10 million07/01/2025$9.07$9.05-0.22%$9.60$8.9740,416 shs$121.00 million06/30/2025$8.99$9.07+0.89%$9.37$9.0240,307 shs$121.27 million Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$8.93$8.99+0.67%$9.08$8.6783,487 shs$120.20 million06/26/2025$9.00$8.93-0.78%$9.03$8.8022,621 shs$119.39 million06/25/2025$9.05$9.00-0.55%$9.15$8.9229,068 shs$120.33 million06/24/2025$8.76$9.05+3.31%$9.19$8.7245,034 shs$120.98 million06/23/2025$8.90$8.76-1.57%$8.95$8.6591,197 shs$117.12 million06/20/2025$8.92$8.90-0.22%$9.08$8.9033,040 shs$118.99 million06/19/2025$8.92$8.92$9.14$8.9234,228 shs$119.24 million06/18/2025$9.03$8.92-1.22%$9.14$8.9234,228 shs$119.26 million06/17/2025$9.20$9.03-1.85%$9.32$9.0064,391 shs$120.71 million06/16/2025$9.20$9.20$9.34$9.1027,956 shs$122.99 million06/13/2025$9.47$9.20-2.85%$9.48$9.2023,025 shs$122.99 million Related Companies BCAX Stock Chart ABVX Stock Chart SEPN Stock Chart ORGO Stock Chart SIGA Stock Chart CGEM Stock Chart ATYR Stock Chart KMDA Stock Chart ATAI Stock Chart TRML Stock Chart Receive GLSI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLSI) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
